Gary Gemignani

Gary Gemignani

Directeur Financier/CFO chez
Solta Medical, Inc.
60 ans
Health Technology
Consumer Services
Finance

Profil

Gary G.
Gemignani
currently works at Algorithm Sciences, Inc., as Director from 2021, Laidlaw Venture Partners, as Director from 2021, and Solta Medical, Inc., as Chief Financial Officer & EVP from 2022.
Mr. Gemignani also formerly worked at IASO Pharma, Inc., as Director from 2010 to 2012, Bluejay Diagnostics, Inc., as Independent Director, Gentium Srl, as Chief Financial Officer & Executive Vice President, Biodel, Inc., as Chief Financial Officer from 2014 to 2016, Fortress Biotech, Inc., as Executive VP, Chief Operating & Financial Officer from 2010 to 2011, Champions Oncology, Inc., as Chief Financial Officer & Executive Vice President from 2011 to 2013, Synergy Pharmaceuticals LLC, as Chief Financial Officer & Executive Vice President from 2017 to 2019, Acacia Pharma Group Ltd., as Chief Financial Officer & Executive Vice President from 2020 to 2022, and Albireo Pharma, Inc., as Chief Financial Officer.
Mr. Gemignani received his undergraduate degree in 1987 from Saint Peter's University.

Postes actifs de Gary Gemignani

SociétésPosteDébut
Directeur/Membre du Conseil 04/10/2021
Directeur/Membre du Conseil 04/10/2021
Directeur Financier/CFO 01/01/2022

Anciens postes connus de Gary Gemignani

SociétésPosteFin
ACACIA PHARMA GROUP PLC Directeur Financier/CFO 23/03/2022
SYNERGY PHARMACEUTICALS INC Directeur Financier/CFO 01/07/2019
CHAMPIONS ONCOLOGY, INC. Directeur Financier/CFO 30/06/2013
FORTRESS BIOTECH, INC. Directeur Financier/CFO 26/09/2011
GENTIUM S.P.A. (ADR) Directeur Financier/CFO 31/03/2010
Voir l'expérience en détail de Gary Gemignani

Formation de Gary Gemignani

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

43

Relations au 1er degré

13

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées13

Health Technology

Health Technology

Health Technology

Health Technology

Consumer Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Finance

  1. Bourse
  2. Insiders
  3. Gary Gemignani